Overview

Gabapentin Versus Estrogen for the Treatment of Hot Flashes

Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy and safety of gabapentin, estrogen and placebo in the treatment of hot flashes and other climacteric symptoms.
Phase:
Phase 4
Details
Lead Sponsor:
University of Rochester
Collaborators:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institutes of Health (NIH)
Treatments:
Estrogens
Gabapentin
gamma-Aminobutyric Acid